Lung metastasis is a rare cause of hemoptysis. Bronchial artery embolization is an effective intervention for treatment of hemoptysis with various underlying etiologies.
INTRODUCTION
In spite of considerable progress in the diagnosis and medical treatments available for hemoptysis, it is still an important and potentially life-threatening condition (1, 2) .
Any bleeding in the airways that is accompanied by breathing insufficiency or hemodynamic imbalance should be solemnly evaluated and treated. Surgery was the only available treatment in the past. Unfortunately, surgical procedures are accompanied by a high mortality and morbidity rates, especially in emergency situations.
Likewise, conservative treatments usually do not have much impact on controlling the bleeding. Since the systemic circulation via the bronchial arteries is responsible for the majority of hemoptysis cases, bronchial artery embolization (BAE) which is a minimally invasive method, can control the bleeding by decreasing the pressure of the abnormal lung parenchyma (2, 3) . This method is recommended as the most important and the most effective procedure for treatment of hemoptysis.
Also in some cases, emergency control of bleeding with embolization makes it possible to perform a non-emergent surgical or bronchoscopic procedure for treating the underlying etiology of hemoptysis (1, 4 infections (Tuberculosis, Aspergillosis) and non-infectious inflammations (Cystic fibrosis, bronchiectasis) (5).
The most common non-inflammatory causes of hemoptysis are lung cancer and congenital heart diseases.
In Iran, based on a study by Attaran et al. on 92 patients with the chief complaint of hemoptysis, the most common etiologies were found to be bronchiectasis (25%), active tuberculosis (21.7%), bronchogenic carcinoma (15%), and unknown causes (7.6%) (6).
Lung metastases can rarely be the reason of hemoptysis. Renal cell carcinoma, thyroid cancer, testicular choriocarcinoma and rarely melanoma are the potentially responsible tumors (7) (8) (9) (10) (11) (12) (13) .
In this case report we present a case of hemoptysis due to multiple pulmonary metastases from malignant melanoma which was successfully treated by BAE. Under continuous fluoroscopy and after confirming the suitable location of the catheter tip, embolization of the common trunk of both bronchial arteries was concomitantly performed using 300-500 micron polyvinyl alcohol (PVA) particles. A control arteriography was performed afterwards which showed embolization of all of the end branches of both bronchial arteries (Figure 4 A,B) .
CASE PRESENTATION
The catheter was then removed and after withdrawing the arterial sheath, hematoma at the puncture site was controlled.
After 4 hours, the patient was transferred to the ward without any problem and was discharged after 2 days. Bronchial arteries are responsible for hemorrhage in more than 90% of cases which will need surgery or bronchial artery embolization (BAE) (15) .
Before introducing BAE, conservative or emergency surgical methods were used to control hemoptysis (1).
Presently, BAE is considered as an effective method with fewer complications for the management of massive hemoptysis due to common causes (2, 3) . Moreover, this method has been used for controlling non-massive or recurrent hemoptysis due to less common causes (14) (15) (16) . Malignant melanoma is the most fatal skin tumor.
Patients with malignant melanoma usually develop metastasis in other cutaneous sites, lymph nodes and lungs (11) . Pulmonary metastases are usually asymptomatic and multiple and are discovered incidentally during imaging evaluation of patients with melanoma.
Our case is interesting from two aspects. First, presentation of pulmonary metastasis with hemoptysis is a rare occurrence and is due to invasion of pulmonary metastasis to airways (9, 11, 12) .
Surgical excision is suggested in cases of single pulmonary metastasis from malignant melanoma (12).
Our patient was a known case of malignant melanoma under treatment for more than 6 years and had a history of incidentally found lung metastasis with new unset of recurrent and retractable hemoptysis.
The second interesting aspect is that, we did not find any report on controlling the hemoptysis due to metastasis of malignant melanoma by BAE in the literature. This is probably due to the fact that embolization techniques are usually used for controlling hemoptysis due to primary lung tumors and benign etiologies.
We used 300-500 µ PVA particles and patient's hemoptysis was successfully controlled in one session.
The most serious complication of BAE is cord ischemia due to unintentional embolization of anterior and posterior spinal arteries through radiculomedullary arteries. It is reported in 1.4-6.5% of cases. Other complications are due to the damage of other organs supplied by bronchial vessels. These include; odynophagia, esophageal necrosis, temporary chest wall pain, myocardial infarction due to vascular anastomosis with coronary arteries and air way necrosis (17) . In spite of these complications in rare cases, BAE is considered as a cost effective method with minimal complications for management of hemoptysis. (18) Fortunately our patient did not develop any complication and was discharged in a very good condition.
CONCLUSION
In this report, we presented bronchial artery embolization (BAE) as a treatment for hemoptysis due to metastatic malignant melanoma in the lungs. Bronchial artery embolization is an interventional radiologic procedure, which effectively controls hemoptysis due to various etiologies, both benign and malignant, such as multiple pulmonary metastases from melanoma.
